Helen Tayton-Martin

Insider Reports History

Location
Abingdon, Oxfordshire, United Kingdom
Signature
/s/ Helen Tayton-Martin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen Tayton-Martin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Chief Business & Strgy Officer Option to purchase Ordinary Shares 565,416 15 Jan 2024 Direct
Trillium Therapeutics Inc. Director Deferred Share Unit 0 17 Nov 2021 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by Helen Tayton-Martin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADAP Adaptimmune Therapeutics PLC 15 Jan 2024 2 $0 4 Chief Business & Strgy Officer 17 Jan 2024, 17:01
ADAP Adaptimmune Therapeutics PLC 17 Jan 2023 3 $0 4 Chief Business & Strgy Officer 17 Jan 2023, 20:04
ADAP Adaptimmune Therapeutics PLC 12 Jan 2022 2 $0 4 Chief Business Officer 13 Jan 2022, 20:03
/report/000110465921141738-tayton-martin-helen-katrina-2021-11-17 Trillium Therapeutics Inc. 17 Nov 2021 2 $0 4 Director 19 Nov 2021, 12:22